Page 78 - Read Online

Genovese et al. Cancer Drug Resist 2018;1:164-80 I http://dx.doi.org/10.20517/cdr.2018.10 Page 177

Rozemuller AJM. Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s
disease. Acta Neuropathol Commun 2018;6:46.
61. Umoh ME, Dammer EB, Dai J, Duong DM, Lah JJ, Levey AI, Gearing M, Glass JD, Seyfried NT. A proteomic network approach across
the ALS-FTD disease spectrum resolves clinical phenotypes and genetic vulnerability in human brain. EMBO Mol Med 2018;10:48-62.
62. Kalathur RK, Giner-Lamia J, Machado S, Barata T, Ayasolla KR, Futschik ME. The unfolded protein response and its potential role in
Huntington’s disease elucidated by a systems biology approach. Version 2. F1000Res 2015;4:103.
63. Gracy KN, Clarke CL, Meyers MB, Pickel VM. N-methyl-D-aspartate receptor 1 in the caudate-putamen nucleus: ultrastructural
localization and co-expression with sorcin, a 22,000 mol. wt calcium binding protein. Neuroscience 1999;90:107-17.
64. Clemen CS, Herr C, Hövelmeyer N, Noegel AA. The lack of annexin A7 affects functions of primary astrocytes. Exp Cell Res
2003;291:406-14.
65. Meyers MB, Biedler JL. Increased synthesis of a low molecular weight protein in vincristine-resistant cells. Biochem Biophys Res
Commun 1981;99:228-35.
66. Van der Bliek AM, Baas F, Van der Velde-Koerts T, Biedler JL, Meyers MB, Ozols RF, Hamilton TC, Joenje H, Borst P. Genes amplified
and overexpressed in human multidrug-resistant cell lines. Cancer Res 1988;48:5927-32.
67. Deng L, Su T, Leng A, Zhang X, Xu M, Yan L, Gu H, Zhang G. Upregulation of soluble resistance-related calcium-binding protein
(sorcin) in gastric cancer. Med Oncol 2010;27:1102-8.
68. Padar S, van Breemen C, Thomas DW, Uchizono JA, Livesey JC, Rahimian R. Differential regulation of calcium homeostasis in
adenocarcinoma cell line A549 and its Taxol-resistant subclone. Br J Pharmacol 2004;142:305-16.
69. Qi J, Liu N, Zhou Y, Tan Y, Cheng Y, Yang C, Zhu Z, Xiong D. Overexpression of sorcin in multidrug resistant human leukemia cells
and its role in regulating cell apoptosis. Biochem Biophys Res Commun 2006;349:303-9.
70. Qu Y, Yang Y, Liu B, Xiao W. Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-
small cell lung cancer. Med Oncol 2010;27:1303-8.
71. Tan Y, Li G, Zhao C, Wang J, Zhao H, Xue Y, Han M, Yang C. Expression of sorcin predicts poor outcome in acute myeloid leukemia.
Leuk Res 2003;27:125-31.
72. Yamagishi N, Nakao R, Kondo R, Nishitsuji M, Saito Y, Kuga T, Hatayama T, Nakayama Y. Increased expression of sorcin is associated
with multidrug resistance in leukemia cells via up-regulation of MDR1 expression through cAMP response element-binding protein.
Biochem Biophys Res Commun 2014;448:430-6.
73. Yang YX, Chen ZC, Zhang GY, Yi H, Xiao ZQ. A subcelluar proteomic investigation into vincristine-resistant gastric cancer cell line. J
Cell Biochem 2008;104:1010-21.
74. Zhou Y, Xu Y, Tan Y, Qi J, Xiao Y, Yang C, Zhu Z, Xiong D. Sorcin, an important gene associated with multidrug-resistance in human
leukemia cells. Leuk Res 2006;30:469-76.
75. Gao Y, Li W, Liu X, Gao F, Zhao X. Reversing effect and mechanism of soluble resistance-related calcium-binding protein on multidrug
resistance in human lung cancer A549/DDP cells. Mol Med Rep 2015;11:2118-24.
76. Sun Y, Wang C, Meng Q, Liu Z, Huo X, Sun P, Sun H, Ma X, Peng J, Liu K. Targeting P-glycoprotein and SORCIN: dihydromyricetin
strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca2+ -mediated apoptosis pathways in MCF-7/ADR and
K562/ADR. J Cell Physiol 2018;233: 3066-79.
77. Dabaghi M, Rahgozar S, Moshtaghian J, Moafi A, Abedi M, Pourabutaleb E. Overexpression of SORCIN is a prognostic biomarker for
multidrug-resistant pediatric acute lymphoblastic leukemia and correlates with upregulated MDR1/P-gp. Genet Test Mol Biomarkers
2016;20:516-21.
78. Maddalena F, Laudiero G, Piscazzi A, Secondo A, Scorziello A, Lombardi V, Matassa DS, Fersini A, Neri V, Esposito F, Landriscina M.
Sorcin induces a drug-resistant phenotype in human colorectal cancer by modulating Ca(2+) homeostasis. Cancer Res 2011;71:7659-69.
79. Tong W, Sun D, Wang Q, Suo J. Sorcin enhances metastasis and promotes epithelial-to-mesenchymal transition of colorectal cancer.
Cell Biochem Biophys 2015;72:453-9.
80. Mangia A, Caldarola L, Dell’Endice S, Scarpi E, Saragoni L, Monti M, Santini D, Brunetti O, Simone G, Silvestris N. The potential
predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first
line chemotherapy. Cancer Biol Ther 2015;16:1140-7.
81. Xu P, Jiang YF, Wang JH. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM
cell lines. Int J Clin Exp Pathol 2015;8:2300-10.
82. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen
JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN,
Mesirov JP, Lander ES, Golub TR. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature
2002;415:436-42.
83. French PJ, Swagemakers SM, Nagel JH, Kouwenhoven MC, Brouwer E, van der Spek P, Luider TM, Kros JM, van den Bent MJ,
Sillevis Smitt PA. Gene expression profiles associated with treatment response in oligodendrogliomas. Cancer Res 2005;65:11335-44.
84. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, Cloughesy TF, Mischel PS, Nelson SF. Gene expression profiling identifies molecular
subtypes of gliomas. Oncogene 2003;22:4918-23.
85. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, Pastorino S, Passaniti A, Menon J, Walling J, Bailey R, Rosenblum M, Mikkelsen T,
Fine HA. Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 2006;9:287-300.
86. Yokota T, Kouno J, Adachi K, Takahashi H, Teramoto A, Matsumoto K, Sugisaki Y, Onda M, Tsunoda T. Identification of histological